Agnes Salamon
Szekszard, TO 7100, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Co-Administration of Proton Pump Inhibitors May Negatively Affect the Outcome in Inflammatory Bowel Disease Treated with Vedolizumab.
Journal: Biomedicines
Published: December 06, 2023
Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease - A nationwide Hungarian cohort study.
Journal: Expert opinion on biological therapy
Published: November 30, 2019
Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort.
Journal: Inflammatory bowel diseases
Published: September 19, 2017
Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort.
Journal: Expert opinion on drug safety
Published: May 16, 2017
Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical And Biochemical Markers Play the More Important Role?
Journal: Journal of Crohn's & colitis
Published: August 30, 2016
Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort.
Journal: Journal of Crohn's & colitis
Published: August 13, 2015
Vitamin D level in Hungarian patients with inflammatory bowel diseases
Journal: Orvosi hetilap
Published: November 12, 2013
Obstetrical and gynecological relevance of inflammatory bowel disease
Journal: Orvosi hetilap
Published: November 14, 2012
The real face of juvenile polyposis syndrome.
Journal: Journal of gastrointestinal oncology
Published: January 04, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026